Jw. Mcdonald et al., ROLE OF GLUTAMATE RECEPTOR-MEDIATED EXCITOTOXICITY IN BILIRUBIN-INDUCED BRAIN INJURY IN THE GUNN RAT MODEL, Experimental neurology, 150(1), 1998, pp. 21-29
Severe hyperbilirubinemia in neonates with prematurity and/or systemic
illnesses such as hemolytic disease, acidosis, and hypoxemia enhances
their risk for developing cerebral palsy, paralysis of ocular upgaze,
and deafness, This neurologic syndrome has been associated with selec
tive neuronal vulnerability in the basal ganglia, certain brainstem nu
clei, and Purkinje cells. However, the mechanism by which bilirubin da
mages neurons remains unclear. In these studies, we found that intrace
rebral injection of N-methyl-D-aspartate (NMDA), an excitotoxic analog
ue of glutamate, caused greater injury in jaundiced 7-day-old Gunn (jj
) rat pups than in nonjaundiced heterozgous (Nj) littermate controls.
NMDA injection caused even greater injury when protein-bound bilirubin
was displaced with the sulfonamide drug sulfadimethoxine in jaundiced
homozygous pups, In additional experiments, the acute signs of biliru
bin-mediated neuronal injury, induced in homozygous (jj) Gunn rats by
treatment with sulfonamide, were reduced by concurrent treatment with
the NMDA-type glutamate channel antagonist -10,11-dihydro-5H-dibenzo[a
,d]cyclohept-5,10-imine (MK-801, dizocilpine). The results suggest tha
t bilirubin may cause encephalopathy and neuronal injury, at least in
part, through an NMDA receptor-mediated excitotoxic mechanism. This co
nclusion is consistent with clinical observations that bilirubin encep
halopathy is synergistically worsened by hypoxemia, which also shares
an excitotoxic mechanism of neuronal injury. (C) 1998 Academic Press.